These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 2852047
1. Selective inhibition of mesolimbic dopamine release following chronic administration of clozapine: involvement of alpha 1-noradrenergic receptors demonstrated by in vivo voltammetry. Lane RF, Blaha CD, Rivet JM. Brain Res; 1988 Sep 20; 460(2):398-401. PubMed ID: 2852047 [Abstract] [Full Text] [Related]
3. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens. Compton DR, Johnson KM. J Pharmacol Exp Ther; 1989 Feb 20; 248(2):521-30. PubMed ID: 2918468 [Abstract] [Full Text] [Related]
4. The effect of chronic clozapine and haloperidol on basal dopamine release and metabolism in rat striatum and nucleus accumbens studied by in vivo microdialysis. Ichikawa J, Meltzer HY. Eur J Pharmacol; 1990 Feb 13; 176(3):371-4. PubMed ID: 2184042 [Abstract] [Full Text] [Related]
5. Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons. Hand TH, Hu XT, Wang RY. Brain Res; 1987 Jul 14; 415(2):257-69. PubMed ID: 3607497 [Abstract] [Full Text] [Related]
6. Chronic treatment with classical and atypical antipsychotic drugs differentially decreases dopamine release in striatum and nucleus accumbens in vivo. Blaha CD, Lane RF. Neurosci Lett; 1987 Jul 22; 78(2):199-204. PubMed ID: 2888060 [Abstract] [Full Text] [Related]
7. Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release. Broderick PA, Piercey MF. J Neural Transm (Vienna); 1998 Jul 22; 105(6-7):749-67. PubMed ID: 9826116 [Abstract] [Full Text] [Related]
8. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain. Wilmot CA, Szczepanik AM. Brain Res; 1989 May 22; 487(2):288-98. PubMed ID: 2525063 [Abstract] [Full Text] [Related]
9. The effect of chronic clozapine on basal dopamine release and apomorphine-induced DA release in the striatum and nucleus accumbens as measured by in vivo brain microdialysis. Chai B, Meltzer HY. Neurosci Lett; 1992 Jun 08; 140(1):47-50. PubMed ID: 1383891 [Abstract] [Full Text] [Related]
10. Chronic haloperidol decreases dopamine release in striatum and nucleus accumbens in vivo: depolarization block as a possible mechanism of action. Lane RF, Blaha CD. Brain Res Bull; 1987 Jan 08; 18(1):135-8. PubMed ID: 3828839 [Abstract] [Full Text] [Related]
11. Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment. Ichikawa J, Meltzer HY. Brain Res; 1990 Jan 15; 507(1):138-42. PubMed ID: 2302571 [Abstract] [Full Text] [Related]
15. The contrasting effects of neuroleptics on transmitter release from the nucleus accumbens and corpus striatum. de Belleroche JS, Neal MJ. Neuropharmacology; 1982 Jun 15; 21(6):529-37. PubMed ID: 6125910 [Abstract] [Full Text] [Related]
16. Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons. Chiodo LA, Bunney BS. J Neurosci; 1985 Sep 15; 5(9):2539-44. PubMed ID: 2863337 [Abstract] [Full Text] [Related]
17. Effects of haloperidol and low dose clozapine on the acetylcholine turnover rate in rat forebrain structures. Bluth R, Langnickel R. Biomed Biochim Acta; 1985 Sep 15; 44(10):1531-9. PubMed ID: 4084256 [Abstract] [Full Text] [Related]